Abbott Laboratories has raised its annual profit forecast and exceeded Wall Street estimates for second-quarter earnings, driven by robust sales of its
Abbott Laboratories has surpassed Wall Street estimates for quarterly profit, buoyed by robust sales of its medical devices, particularly glucose-monitoring products. The